Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 401–500 of 1,000
Chen, Z., Zhou, Y., Xue, C., Zeng, L., Deng, S., Xu, Z., Li, M., Zhao, H., He, X., Liu, S., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01667-0 · Cited by 57
Reciprocal regulation of PKA and Rac signaling
Bachmann, V. A., Riml, A., Huber, R. G., Baillie, G. S., Liedl, K. R., Valovka, T., & Stefan, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215902110 · Cited by 55
Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
Lee, S. J., Ghosh, S. C., Han, H. D., Stone, R. L., Bottsford-Miller, J. N., Shen, D.-Y., Auzenne, E. J., Lopez-Araujo, A., Lü, C., Nishimura, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3250 · Cited by 49
“Cell lines and culture Thehuman epithelial ovarian cancer cell lines SKOV3ip1, HeyA8, and HeyA8-MDR (taxane-resistant) have been described previously (31, 32).”
BackgroundSelf-citationNeurotransmitter Receptors as Central Regulators of Pancreatic Cancer
Schuller, H. M., & Al-Wadei, H. A. N. (2010) · Future Oncology · doi:10.2217/fon.09.171 · Cited by 52
Deng, Q., Chen, H., Liu, Y., Xiao, F., Guo, L., Liu, D., Cheng, X., Zhao, M., Wang, X., Xie, S., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.017 · Cited by 51
Biphasic effects of propranolol on tumour growth in B16F10 melanoma‐bearing mice
Maccari, S., Buoncervello, M., Rampin, A., Spada, M., Macchia, D., Giordani, L., Stati, T., Bearzi, C., Catalano, L., Rizzi, R., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13662 · Cited by 49
“Additionally, other preclinical studies have shown that activation of β-adrenoceptors promotes angiogenesis (Iaccarino et al., 2005; Thaker et al., 2006; Xu et al., 2015).”
BackgroundRamondetta, L. M., Hu, W. M., Thaker, P. H., Urbauer, D. L., Chisholm, G. B., Westin, S. N., Sun, Y., Ramirez, P. T., Fleming, N. D., Sahai, S. K., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.07.004 · Cited by 50
“Preclinical evidence supports that sustained adrenergic activation can promote ovarian cancer growth and metastasis and many of the stimulatory effects of SNS on tumor biology can be blocked by propranolol [10, 21, 22].”
BackgroundSelf-citationHalmin, M., Bellocco, R., Lagerlund, M., Karlsson, P., Tejler, G., & Lambe, M. P. (2008) · Acta Oncologica · doi:10.1080/02841860701769768 · Cited by 50
“Tumours in stressed animals showed increased vascularisation, pointing towards the effects of stress on tumour growth being mediated by angiogenic processes [28].”
BackgroundAttenuation of Choroidal Neovascularization by β2-Adrenoreceptor Antagonism
Lavine, J. A., Sang, Y., Wang, S., Ip, M. S., & Sheibani, N. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.1476 · Cited by 49
Sympathetic nervous tone limits the development of myeloid-derived suppressor cells
Nevin, J. T., Moussa, M. R., Corwin, W. L., Măndoiu, I., & Srivastava, P. K. (2020) · Science Immunology · doi:10.1126/sciimmunol.aay9368 · Cited by 51
Pathophysiologic Role of Neurotransmitters in Digestive Diseases
Yang, X., Lou, J., Shan, W., Ding, J., Jin, Z., Hu, Y., Du, Q., Liao, Q., Xie, R., & Xu, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.567650 · Cited by 50
Wang, L., Ge, J., Han, H., Jia, Y., & Qin, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216986 · Cited by 51
Sympathetic Neurons Promote Small Cell Lung Cancer through the β2-Adrenergic Receptor
Tala, F. N. U., Shi, P., Zhang, W., Chung, S. S. W., Damoci, C. B., Fang, Y., Chen, Q., Saqi, A., Huang, Y., Wu, X., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0718 · Cited by 58
Wilson, J. M., Lorimer, E., Tyburski, M. D., & Williams, C. L. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1070988 · Cited by 49
Aydıner, A., Çiftçi, R., Karabulut, S., & Kılıç, L. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.6109 · Cited by 48
“, 2006), ovary (Sood et al., 2006; Thaker et al., 2006), breast (Drell et al.”
BackgroundInvolvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment
Shalabi, S., Belayachi, A., & Larrivée, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1284629 · Cited by 54
“…to the release of Norepinephrine (NE) and Epinephrine (EPI), also enhance tumor neovascularization in primary ovarian tumors by upregulating the expression of VEGF and MMPs, which could also underlie the effects of b -blockers, which have been found to reverse stress-enhanced angiogenesis (261).”
BackgroundSphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
Lee, J., Ryu, J., Yoon, G., Jeon, H., Cho, Y., Choi, J., Song, S. Y., Do, I., Lee, Y.-Y., Kim, T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29362 · Cited by 47
“2 ml HBSS) were injected into the peritoneal cavity of mice.(18) For the patient-derived xenograft (PDX) model of EOC, surgical patient tumor specimens were reduced into small pieces (less than 2–3 mm), implanted into the subrenal capsule of the left kidney,(19) and propagated by serial transplantation.”
MethodSelf-citationReduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter
Asada, M., Ebihara, S., Numachi, Y., Okazaki, T., Yamanda, S., Ikeda, K., Yasuda, H., Sora, I., & Arai, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23562 · Cited by 50
Octopamine connects nutrient cues to lipid metabolism upon nutrient deprivation
Tao, J., Ma, Y., Yang, Z., Zou, C., & Zhang, K. (2016) · Science Advances · doi:10.1126/sciadv.1501372 · Cited by 47
Neurotransmitters: promising immune modulators in the tumor microenvironment
Xiao, L., Li, X., Fang, C., Yu, J., & Chen, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1118637 · Cited by 50
Heitz, F., du Bois, A., Harter, P., Lübbe, D., Kurzeder, C., Vergote, I. B., Plante, M., & Pfisterer, J. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.007 · Cited by 48
Filippi, L., Monte, M. D., Casini, G., Daniotti, M., Sereni, F., & Bagnoli, P. (2014) · Medicinal Research Reviews · doi:10.1002/med.21336 · Cited by 51
Bruzzone, A., Piñero, C. P., Rojas, P. A., Romanato, M., Gass, H., Lanari, C., & Lüthy, I. A. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911796191051 · Cited by 46
“ovary SKOV3ip1 cells growing in stressed nude mice showed markedly increased tumor growth, vascularization and enhanced expression of VEGF, MMP2 and MMP9 by adrenergic activation of the cAMP–PKA signaling pathway [41].”
BackgroundVLM catecholaminergic neurons control tumor growth by regulating CD8 + T cells
Zhang, Z., Li, Y., Lv, X., Zhao, L., & Wang, X. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103505118 · Cited by 55
Self-citationTrial watch: beta-blockers in cancer therapy
Provost, K. C. L., Kepp, O., Kroemer, G., & Bezu, L. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2284486 · Cited by 49
“11 Similar results were observed in mice exposed to psychosocial stress through crowded or isolated housing conditions where stress-enhanced melanoma and fibrosarcoma growth was decreased by the oral administration of propranolol.”
ResultJang, H.-I., Lim, S., Lee, Y.-Y., Kim, T., Choi, C. H., Lee, J., Kim, B., & Bae, D. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.2.170 · Cited by 46
“And the mechanisms for these changes may be through the increase in catecholamines; they are known to act directly on malignant cells, activating several processes that are critical for tumor metastatic activity, including tumor cell proliferation [16,17], extracellular matrix invasion capacity [16], resistance to apo…”
BackgroundSelf-citationMessmer, M. N., Kokolus, K. M., Eng, J. W. ‐., Abrams, S. I., & Repasky, E. A. (2014) · BioEssays · doi:10.1002/bies.201400066 · Cited by 50
“It is important to note that NE can also stimulate adrenergic receptor positive tumor cells directly to promote tumor growth and metastasis via immune-independent pathways [41, 71].”
BackgroundLi, Z. J., & Cho, C. H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.077 · Cited by 46
Al-Wadei, H. A. N., Al-Wadei, M. H., Ullah, M. F., & Schuller, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043376 · Cited by 45
“diseases in men and women worldwide [18,37,47,50] and that pancreatic cancer patients demonstrate particularly high levels of”
BackgroundCoping and Quality of Life in Turkish Women Living with Ovarian Cancer
Tuncay, T. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.9.4005 · Cited by 51
“Other research findings indicated that coping by seeking social support was associated with better outcomes with respect to social well-being, physician–patient relationships, distress, functional status, and clinical status (Lutgendorf et al., 2003; Sood et al., 2006; Thaker et al., 2006).”
BackgroundLack of Patient-Clinician Concordance in Cancer Patients: Its Relation With Patient Variables
Chandwani, K. D., Zhao, F., Morrow, G. R., Deshields, T. L., Minasian, L. M., Manola, J. B., & Fisch, M. J. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.12.347 · Cited by 51
“Distress as a factor significantly associated with LOC of patients’ bother is an important observation because detrimental effects of distress on cancer patients’ physical and mental health and their immune system could impede their recovery from cancer and may actually facilitate disease progression (31, 32).”
BackgroundChinnapaka, S., Bakthavachalam, V., & Munirathinam, G. (2020) · PubMed · Cited by 48
High nerve density in breast cancer is associated with poor patient outcome
Li, D., Hu, L. N., Zheng, S. M., La, T., Wei, L., Zhang, X. J., Zhang, Z. H., Xing, J. W., Wang, L., Li, R. Q., et al. (2022) · FASEB BioAdvances · doi:10.1096/fba.2021-00147 · Cited by 48
Falcinelli, M., Alhity, G., Baron, S., Mampay, M., Allen, M. C., Samuels, M. E., Jones, W., Cilibrasi, C., Flaherty, R. L., Giamas, G., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.011 · Cited by 49
“We also examined several immune-related markers such as VEGF, Granzyme B, CXCL10 and IDO1 based on their previously reported roles in the TME (Supplementary Fig.”
BackgroundMethodInfluentialSelf-citationHe, B., Gao, R., Lv, S., Chen, A., Huang, J., Wang, L., Feng, Y., Feng, J., Liu, B., Lei, J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01487-4 · Cited by 47
“9,10,14,15 Norepinephrine activated adrenergic receptors modulate the activity of transmembrane adenylyl cyclase, which generates 3 ’ ,5 ’ -cyclic adenosine monophosphate (cAMP) to control cellular response to neural signals.”
Self-citationPerino, A., Beretta, M., Kilić, A., Ghigo, A., Carnevale, D., Repetto, I. E., Braccini, L., Longo, D. L., Liebig‐Gonglach, M., Zaglia, T., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005485 · Cited by 46
Propranolol for the treatment of vascular sarcomas
Wagner, M. J., Cranmer, L. D., Loggers, E. T., & Pollack, S. M. (2018) · Journal of Experimental Pharmacology · doi:10.2147/jep.s146211 · Cited by 44
“Preclinical studies in cancer models have demonstrated that increased adrenergic signaling through the β-2 receptor results in increased VEGF production in cancer cells(29) and increased tumor vascularization.(30) Similarly, the β-agonist isoprenaline stimulates autocrine VEGF signaling in gastric cancer cells and ass…”
Beta-Adrenergic Signaling in Tumor Immunology and Immunotherapy
Wang, W., & Cao, X. (2019) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2019031188 · Cited by 47
Dopamine D1 Receptor in Cancer
Sobczuk, P., Łomiak, M., & Cudnoch‐Jędrzejewska, A. (2020) · Cancers · doi:10.3390/cancers12113232 · Cited by 46
Biological Pathways Linking Mindfulness with Health
Creswell, J. D. (2018) · Figshare · doi:10.1184/r1/6613724 · Cited by 44
Ma, X., Zhao, Y. Q., Daaka, Y., & Nie, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352260 · Cited by 44
“The activation of 2AR promotes angiogenesis, and growth and invasion of ovarian tumors in xenograft mouse model (14).”
BackgroundAdrenoceptors: Non Conventional Target for Breast Cancer?
Lüthy, I. A., Bruzzone, A., Piñero, C. P., Castillo, L., Chiesa, I. J., Vazquez, S., & Sarappa, M. G. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186048 · Cited by 43
“2-AR mediated enhanced tumor angiogenesis in an orthotopic model of ovary cancer [29].”
BackgroundInfluentialLiu, J., Qu, L., Wan, C., Xiao, M., Ni, W., Jiang, F., Fan, Y., Lu, C., & Ni, R. (2020) · Oncogenesis · doi:10.1038/s41389-020-00268-w · Cited by 49
Self-citationIsoprenaline induces epithelial–mesenchymal transition in gastric cancer cells
Lu, Y., Geng, Z., Sun, X., Li, Y., Fu, X., Zhao, X., & Wei, B. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2477-0 · Cited by 47
Self-citationActivation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma
He, J., Zhang, W., Liu, S., Chen, Y., Liao, C.-X., Shen, Q., & Hu, P. (2017) · Oncology Letters · doi:10.3892/ol.2017.6653 · Cited by 47
“This alteration in homeostasis leads to a microenvironment that is beneficial to tumor growth and progression in experimental models of disease (5).”
Borghese, B., Santulli, P., Marcellin, L., & Chapron, C. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.02.017 · Cited by 75
Beta‐blockers exert potent anti‐tumor effects in cutaneous and uveal melanoma
Bustamante, P., Miyamoto, D., Goyeneche, A. A., Graue, P. G. D. A., Jin, E., Tsering, T., Dias, A. B. T., Burnier, M. N., & Burnier, J. V. (2019) · Cancer Medicine · doi:10.1002/cam4.2594 · Cited by 42
Promoter aberrant methylation status ofADRA1Ais associated with hepatocellular carcinoma
Chen, G., Fan, X., Li, Y., He, L., Wang, S., Dai, Y., Bin, C., Zhou, D., & Lin, H. M. (2020) · Epigenetics · doi:10.1080/15592294.2019.1709267 · Cited by 44
“In ovarian carcinoma, betaadrenergic activation of the 3′,5′-cyclicadenosine monophosphate (cAMP)-protein kinase A (PKA) signalling pathway can enhance tumour angiogenesis, and blocking ADRB could diminish the numbers and weight of tumours in stressed mice [24].”
BackgroundSelf-citationTorregrosa, C., Chorin, F., Beltran, E. E. M., Neuzillet, C., & Cardot‐Ruffino, V. (2022) · Cancers · doi:10.3390/cancers14215402 · Cited by 54
“Indeed, the stress-induc d activation of the ypo halamus xis and corticosteroids r leased during exe cise ca accelerate the tumor growth [60] and hav vari us negative effects on the immune response [159], which counterbalance the potential beneficial effect of exercise on the tumor growth (Figure 5).”
BackgroundExogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model
Deng, G.-H., Liu, J., Zhang, J., Wang, Y., Peng, X., Wei, Y.-Q., & Jiang, Y. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-21 · Cited by 50
“tive β-AR antagonist, propranolol [7-9,13-18].”
BackgroundInfluentialNervous system regulation of the cancer genome
Cole, S. W. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.11.008 · Cited by 41
Self-citationUnderstanding and modeling nerve–cancer interactions
Le, T. T., & Oudin, M. J. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049729 · Cited by 43
“The role of β -adrenergic receptors in lung and ovarian cancer has also been extensively studied (Huang et al., 2018; Nilsson et al., 2020; Thaker et al., 2006).”
Fuemmeler, B. F., Shen, J., Zhao, H., & Winn, R. A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02006-1 · Cited by 47
“For example, catecholamines can trigger the cAMP-protein kinase A (PKA) signaling pathway [65, 66], which further leads to inducing DNA damage, degrading p53, and up-regulating vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP-2 and MMP-9).”
BackgroundZhou, H., Zhu, C., Zhao, Q. C., Ni, J., Zhang, H., Yang, G., Ge, J., Fang, C., Wei, H., Zhou, X., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.022 · Cited by 42
“Furthermore, catecholamines could significantly promote the expression of angiogenic factors including vascular endothelial growth factor (VEGF) and aggravate tumor microvascularization [16].”
Wan, C., Chen, G., Zhang, H., Hua, L., Li, X., Chen, X., Chen, Y., Ding, X., He, S., Cao, W., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.026 · Cited by 43
5‑HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability
Ballou, Y., Rivas, A., Belmont, A., Patel, L., Amaya, C. N., Lipson, S., Khayou, T., Dickerson, E. B., Nahleh, Z. A., & Bryan, B. A. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1681 · Cited by 46
“Along these lines, a growing amount of literature has shown that stress in general, and specifically sympathetic nervous system responses through epinephrine and/or norepinephrine regulation of the β adrenergic receptor pathways have been implicated in cancer progression (29,55-57).”
Zhao, Y., Jia, Y., Shi, T., Wang, W., Shao, D., Zheng, X., Sun, M., He, K., & Chen, L. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz017 · Cited by 49
Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells
Lamboy-Caraballo, R., Ortíz, C., Acevedo‐Santiago, A., Matta, J. L., Monteiro, Á. N. A., & Armaiz-Peña, G. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062250 · Cited by 43
“While each adrenergic receptor sub-type (α and β) leads to different physiologic functions, the effects of adrenergic signaling in EOC have been shown to be largely mediated by β-adrenergic receptors in tumor cells, specially stimulation β2-AR [6,14,18,21,22,25].”
BackgroundPost-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer
Assayag, J., Pollak, M., & Azoulay, L. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.08.006 · Cited by 41
“Our null findings, despite promising animal models, can perhaps be explained by higher doses and a stronger sympathetic response in mouse models [4,31–34].”
BackgroundFiala, O., Ostašov, P., Šorejs, O., Liška, V., Büchler, T., Poprach, A., & Fínek, J. (2019) · Cancers · doi:10.3390/cancers11121856 · Cited by 40
“These cancer-related processes include promotion of cell proliferation [21,22], evasion of apoptosis [13,23], tissue invasion mediated by matrix metalloproteinases (MMP) [24], cancer cell mobilisation and motility [8,25], expression of proinflammatory cytokines such as interleukin 6 (IL-6) and IL-8 by both cancer and…”
BackgroundZhang, H., Yang, Y., Cao, Y., & Guan, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116609 · Cited by 47
Health, wartime stress, and unit cohesion: Evidence from Union Army veterans
Costa, D. L., & Kahn, M. E. (2010) · Demography · doi:10.1353/dem.0.0095 · Cited by 43
Monami, M., Filippi, L., Ungar, A., Sgrilli, F., Antenore, A., Dicembrini, I., Bagnoli, P., Marchionni, N., Rotella, C. M., & Mannucci, E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.772505 · Cited by 42
Early impact of social isolation and breast tumor progression in mice
Madden, K. S., Szpunar, M. J., & Brown, E. B. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.003 · Cited by 45
Social psychogenic stress promotes the development of endometriosis in mouse
Guo, S., Zhang, Q., & Liu, X. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.11.012 · Cited by 41
“Indeed, ADRB2 has been shown to be responsible for stress-induced promotion of tumour development (Thaker et al., 2006) and metastasis (Nagaraja et al., 2016) and also for the stress-induced acceleration of endometriosis development (Long et al., 2016a, 2016b).”
BackgroundGarg, J., Feng, Y., Jansen, S. R., Friedrich, J., Lezoualc’h, F., Schmidt, M., & Wieland, T. (2017) · Oncotarget · doi:10.18632/oncotarget.17267 · Cited by 40
“The pharmacologic dissection of preclinical models of ovarian and prostate cancer revealed that catecholamine effects are mediated predominantly by β2ARs [40, 41].”
BackgroundNorepinephrine‐CREB1‐miR‐373 axis promotes progression of colon cancer
Han, J., Jiang, Q., Ma, R., Zhang, H., Tong, D., Tang, K., Wang, X., Ni, L., Miao, J., Duan, B., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12657 · Cited by 41
“In addition to directly promoting the growth of cancer cells, NE has been reported to be associated with increased expression of vascular endothelial growth factor and with the development of abundant tumor vascularization that facilitates tumor progression (Faulkner et al., 2019; Magnon, 2015; Thaker et al., 2006).”
BackgroundInfluentialStress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis
Hanns, P., Paczulla, A., Medinger, M., Konantz, M., & Lengerke, C. (2019) · Cell Stress · doi:10.15698/cst2019.07.192 · Cited by 42
“AUTONOMOUS MECHANISMS Experimental data indicate that stress and catecholamines promote tumor growth and metastasis via both cell autonomous and non-autonomous mechanisms [17, 44-56] (see also the recent review by Qiao et al.”
MethodWu, Y., Luo, X., Zhou, Q., Gong, H., Gao, H., Liu, T., Chen, J., Liang, L., Kurihara, H., Li, Y.-F., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.002 · Cited by 41
Self-citationConverging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma
Spannuth, W. A., Mangala, L. S., Stone, R. L., Carroll, A. R., Nishimura, M., Shahzad, M. M. K., Lee, S., Moreno‐Smith, M., Nick, A. M., Liu, R., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0200 · Cited by 39
Self-citationc-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
Kim, H.-J., Yoon, A., Ryu, J., Cho, Y., Choi, J., Song, S. Y., Bang, H., Lee, J. S., Cho, W. C. S., Choi, C. H., et al. (2016) · Scientific Reports · doi:10.1038/srep38502 · Cited by 41
Lin, X., Liu, H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D., Cui, J., Ren, Z., & Chen, R. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01568-0 · Cited by 45
Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide?
Iftikhar, A., Islam, M. R., Shepherd, S. D., Jones, S., & Ellis, I. (2021) · Cancers · doi:10.3390/cancers13020163 · Cited by 48
“The expression of β2-adrenergic receptors on gastric cancer tissues was higher than normal samples and activation of these receptors was related to increased malignancy of gastric cancer [146].”
Backgroundβ2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma Cells
Toll, L., Jimenez, L., Waleh, N. S., Jóźwiak, K., Woo, A. Y., Xiao, R.-P., Bernier, M., & Wainer, I. W. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173971 · Cited by 39
“For example, activation of 2-AR increased tumor angiogenesis and enhanced the expression of vascular endothelial growth factor and metalloproteinases in a mouse model of ovarian carcinoma through activation of the cAMP/PKA signaling pathway (Thaker et al., 2006).”
BackgroundKumar, N., Prasad, P., Jash, E., Saini, M., Husain, A., Goldman, A. J., & Sehrawat, S. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3294-z · Cited by 39
“Mice studies have also elucidated the involvement of beta-adrenergic activation of cAMP/PKA signaling pathway, which interacts with EPAC, in angiogenesis through chronic stress [84].”
Role of natural products in breast cancer related symptomology: Targeting chronic inflammation
Andrijauskaite, K., & Wargovich, M. J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.011 · Cited by 38
Cardiovascular Disease and Cancer: A Dangerous Liaison
Newman, A. A. C., Dalman, J. M., & Moore, K. J. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319863 · Cited by 40
Gronowicz, G., Secor, E. R., Flynn, J. R., Jellison, E. R., & Kuhn, L. T. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/926565 · Cited by 56
Lu, Y., Xu, Q., Zuo, Y., Liu, L., Liu, S., Chen, L., Wang, K., Lei, Y., Zhao, X., & Li, Y. (2017) · BMC Cancer · doi:10.1186/s12885-017-3894-0 · Cited by 39
“demonstrated that β2-AR was a critical mediator for stress-induced acceleration in ovarian cancer by promoting angiogenesis [16].”
BackgroundSelf-citationBaek, M., Kim, D., Kim, S., Kim, Y., & Park, Y. H. (2018) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e82 · Cited by 39
“Surprisingly, these pathways were found to be downregulated and even reversed when beta blockers (BBs) were administered to mice in previous preclinical studies [12-14].”
BackgroundCirculating epinephrine is not required for chronic stress to enhance metastasis
Walker, A. K., Martelli, D., Ziegler, A. I., Lambert, G. W., Phillips, S. E., Hill, S. J., McAllen, R. M., & Sloan, E. K. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.012 · Cited by 42
Monte, M. D., Calvani, M., Cammalleri, M., Favre, C., Filippi, L., & Bagnoli, P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14552 · Cited by 39
“In addition, in a mouse model of ovarian carcinoma, chronic stress induces an increase in NA associated with a β2-adrenoceptor-mediated growth of carcinoma cells, an effect that is abolished by propranolol (Thaker et al., 2006).”
Xu, X., Xiao, Q., Hong, Y., Liu, Y., Liu, Y., & Tu, J. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13465 · Cited by 39
The Influence of Psychological Stress on HPV Infection Manifestations and Carcinogenesis
Lugović‐Mihić, L., Cvitanović, H., Djaković, I., Kuna, M., & Šešerko, A. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000395 · Cited by 51
Archer, M., Dogra, N., Dovey, Z., Ganta, T., Jang, H., Khusid, J. A., Lantz, A. W., Mihalopoulos, M., Stockert, J. A., Zahalka, A. H., et al. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00755-6 · Cited by 44
“Tumor-associated endothelial cells are also sensitive to catecholamines [4, 49, 172], consequently implicating targeting of tumor”
BackgroundCentral and peripheral nervous systems: master controllers in cancer metastasis
Shi, M., Liu, D., Yang, Z., & Guo, N. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9440-x · Cited by 43
“threefold increase of blood vessel density in primary mammary tumors, and β-blocker reversed stress-enhanced angiogenesis [62].”
BackgroundInfluentialPsychosocial Factors and Disease Progression in Cancer
Antoni, M. H., & Lutgendorf, S. K. (2007) · Current Directions in Psychological Science · doi:10.1111/j.1467-8721.2007.00472.x · Cited by 51
“In a mouse model of ovarian cancer, chronic restraint stress has been shown to result in greater tumor burden and more invasive tumor growth—effects resulting from betaadrenergic signaling and increased tumor vascularization (Thaker et al., 2006).”
BackgroundSelf-citationChronic stress promotes glioma cell proliferation via the PI3K/Akt signaling pathway
Zhang, Z., Wang, X., Xue, B.-H., Zhao, Y. F., Xie, F., Wang, S.-D., Xue, C., Wang, Y., Zhang, Y., & Qian, L. (2021) · Oncology Reports · doi:10.3892/or.2021.8153 · Cited by 40
“To explore the effects of chronic stress on glioma growth, U87MG cells were subcutaneously injected into nude mice and a well‑established chronic restraint stress model was adopted as previously described (17,31).”
Local anesthetics elicit immune-dependent anticancer effects
Bezu, L., Chuang, A. W., Sauvat, A., Humeau, J., Xie, W., Cerrato, G., Liu, P., Zhao, L., Zhang, S., Naour, J. L., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004151 · Cited by 38
HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition
Hu, H.-T., Ma, Q.-Y., Zhang, D., Shen, S.-G., Han, L., Ma, Y.-D., Li, R.-F., & Xie, K.-P. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.181 · Cited by 46
Self-citationBarr, J. L., Walz, A., Restaino, A. C., Amit, M., Barclay, S. M., Vichaya, E. G., Spanos, W. C., Dantzer, R., Talbot, S., & Vermeer, P. D. (2024) · eLife · doi:10.7554/elife.97916 · Cited by 39
“These alterations could be attributed to depression ( Walker et al., 2014 ) or represent a competition between the energy demands of the HNSCC malignant cells and the host’s skeletal muscles ( Grossberg et al., 2020 ; Thaker et al., 2006 ; Kim-Fuchs et al., 2014 ).”
Zhang, L., Pan, J., Wang, M., Yang, J., Zhu, S., Li, L., Hu, X., Wang, Z., Pang, L., Li, P., et al. (2024) · Advanced Science · doi:10.1002/advs.202310266 · Cited by 64
Bruzzone, A., Saulière, A., Finana, F., Sénard, J., Lüthy, I. A., & Galès, C. (2013) · The FASEB Journal · doi:10.1096/fj.13-239285 · Cited by 47
“cancer progression (11) via a PKA-Src-dependent”
Cancer catecholamine conundrum
Wackerhage, H., Christensen, J. F., Ilmer, M., von Luettichau, I., Renz, B. W., & Schönfelder, M. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.005 · Cited by 38
Benish, M., & Ben-Eliyahu, S. (2010) · Cancers · doi:10.3390/cancers2041929 · Cited by 34
“Consequently, these processes led to enhanced tumor vascularization and a more aggressive growth and spread of malignant cells [67].”
BackgroundModulation of Angiogenic Phenotype Alters Tumorigenicity in Rat Ovarian Epithelial Cells
Schumacher, J. J., Dings, R. P. M., Cosin, J. A., Subramanian, I. V., Auersperg, N., & Ramakrishnan, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3608 · Cited by 39
Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer
Huang, T., Poole, E. M., Eliassen, A. H., Okereke, O. I., Kubzansky, L. D., Sood, A. K., Forman, J. P., & Tworoger, S. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30066 · Cited by 37
“Particularly, laboratory data suggest that beta-blockers may antagonize the tumorpromoting actions of endogenous catecholamines signaling through beta2-adrenergic receptors expressed in ovarian cancer cells.(10,11) Improved survival associated with beta-blocker use in ovarian cancer patients has been observed in some,…”
BackgroundSelf-citationBeta‐blockers may reduce intrusive thoughts in newly diagnosed cancer patients
Lindgren, M. E., Fagundes, C. P., Alfano, C. M., Povoski, S. P., Agnese, D. M., Arnold, M. W., Farrar, W. B., Yee, L. D., Carson, W. E., Schmidt, C. R., et al. (2013) · Psycho-Oncology · doi:10.1002/pon.3233 · Cited by 35
“Increasing evidence suggests that catecholamines accelerate tumor cell growth by stimulating angiogenesis, a first step in malignant transformation whereby additional vascular networks are recruited to the site of the primary tumor [33,34].”
Oxidative Stress Promotes Liver Cancer Metastasis via RNF25‐Mediated E‐Cadherin Protein Degradation
Huang, Z., Zhou, L., Duan, J., Qin, S., Wang, Y., JIANG, J., Jin, P., Liu, R., Luo, M., He, B., et al. (2024) · Advanced Science · doi:10.1002/advs.202306929 · Cited by 49
Nerves at Play: The Peripheral Nervous System in Extracranial Malignancies
Vermeer, P. D., Restaino, A. C., Barr, J. L., Yaniv, D., & Amit, M. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0397 · Cited by 37
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.